Nakane K - Search Results

1

Induction of cytotoxic T lymphocytes against human cancer cell lines using dendritic cell-tumor cell hybrids generated by a newly developed electrofusion technique.

Imura K, Ueda Y, Hayashi T, Itoh T, Shimizu K, Tamai H, Yano Y, Naito K, Kohara J, Nakane K, Matsuura Y, Takeda A, Takeda T, Kawai K, Yamagishi H. Imura K, et al. Among authors: nakane k. Int J Oncol. 2006 Sep;29(3):531-9. Int J Oncol. 2006. PMID: 16865268

2

[Immunogenic reactivity of CTLs induced by electrofusion cells of human dendritic cells and gastric cancer cells].

Imura K, Hayashi T, Yano Y, Naito K, Kouhara J, Ueda Y, Nakane K, Matsuura Y, Takeda A, Takeda T, Kawai K, Yamagishi H. Imura K, et al. Among authors: nakane k. Gan To Kagaku Ryoho. 2004 Oct;31(11):1797-9. Gan To Kagaku Ryoho. 2004. PMID: 15553719 Japanese.

3

A new strategy using autologous dendritic cells and lymphokine-activated killer cells for cancer immunotherapy: efficient maturation of DCs by co-culture with LAK cells in vitro.

Yano Y, Ueda Y, Itoh T, Fuji N, Okugawa K, Naito K, Imura K, Kohara J, Hayashi T, Nakane K, Matsuura Y, Kawai K, Yamagishi H. Yano Y, et al. Among authors: nakane k. Oncol Rep. 2006 Jul;16(1):147-52. Oncol Rep. 2006. PMID: 16786138

4

Non-clinical efficacy, safety and stable clinical cell processing of induced pluripotent stem cell-derived anti-glypican-3 chimeric antigen receptor-expressing natural killer/innate lymphoid cells.

Ueda T, Kumagai A, Iriguchi S, Yasui Y, Miyasaka T, Nakagoshi K, Nakane K, Saito K, Takahashi M, Sasaki A, Yoshida S, Takasu N, Seno H, Uemura Y, Tamada K, Nakatsura T, Kaneko S. Ueda T, et al. Among authors: nakane k. Cancer Sci. 2020 May;111(5):1478-1490. doi: 10.1111/cas.14374. Epub 2020 Mar 31. Cancer Sci. 2020. PMID: 32133731 Free PMC article.

5

The prognostic superiority of second-generation androgen receptor signaling inhibitor in patients with non-metastatic castration-resistant prostate cancer.

Naiki T, Takahara K, Watanabe H, Nakane K, Sugiyama Y, Koie T, Shiroki R, Miyake H, Yasui T. Naiki T, et al. Among authors: nakane k. Jpn J Clin Oncol. 2024 Oct 30:hyae155. doi: 10.1093/jjco/hyae155. Online ahead of print. Jpn J Clin Oncol. 2024. PMID: 39475446

6

Overall Survival and Cancer-Specific Mortality in Patients with Prostate Cancer Undergoing Definitive Therapies: A Narrative Review.

Kawase M, Nakane K, Iinuma K, Kawase K, Taniguchi T, Tomioka M, Tobisawa Y, Koie T. Kawase M, et al. Among authors: nakane k. J Clin Med. 2024 Sep 19;13(18):5561. doi: 10.3390/jcm13185561. J Clin Med. 2024. PMID: 39337047 Free PMC article. Review.

7

In vivo -Active Soluble Epoxide Hydrolase-targeting PROTACs with Improved Potency and Stability.

Nakane K, Morisseau C, Dowker-Key PD, Benitez G, Aguilan JT, Nagai E, Sidoli S, Hammock BD, Bettaieb A, Shinoda K, Kitamura S. Nakane K, et al. bioRxiv [Preprint]. 2024 Jul 24:2024.07.23.604814. doi: 10.1101/2024.07.23.604814. bioRxiv. 2024. PMID: 39211216 Free PMC article. Preprint.

8

Prognostic factors for non‑metastatic castration‑resistant prostate cancer treated with androgen receptor signaling inhibitors.

Takahara K, Naiki T, Nakane K, Watanabe H, Miyake H, Koie T, Yasui T, Shiroki R. Takahara K, et al. Among authors: nakane k. Mol Clin Oncol. 2024 Aug 8;21(4):74. doi: 10.3892/mco.2024.2772. eCollection 2024 Oct. Mol Clin Oncol. 2024. PMID: 39170625 Free PMC article.

9

Combination approach using neoadjuvant therapy with radical prostatectomy for improving oncological outcomes of high-risk prostate cancer: a narrative review.

Nakane K, Kawase M, Kato D, Iinuma K, Kawase K, Takeuchi S, Tobisawa Y, Ito T, Koie T. Nakane K, et al. Transl Cancer Res. 2024 Jul 31;13(7):3889-3897. doi: 10.21037/tcr-23-2394. Epub 2024 Jul 8. Transl Cancer Res. 2024. PMID: 39145084 Free PMC article. Review.

10

Oncologic Outcomes of Patients with Immune Checkpoint Inhibitor Resistant Urothelial Carcinoma Treated with Enfortumab Vedotin and the Impact of Neutrophil-to-Lymphocyte Ratio and Dysgeusia on Overall Survival: A Retrospective Multicenter Cohort Study in Japan.

Nakane K, Taniguchi K, Nezasa M, Enomoto T, Yamada T, Tomioka-Inagawa R, Niwa K, Tomioka M, Ishida T, Nagai S, Yokoi S, Taniguchi T, Kawase M, Kawase K, Iinuma K, Tobisawa Y, Koie T. Nakane K, et al. Cancers (Basel). 2024 Jul 25;16(15):2648. doi: 10.3390/cancers16152648. Cancers (Basel). 2024. PMID: 39123376 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

269 results

Search Page

Filters